Wilmer Cutler Pickering Hale and Dorr has advised Enavate Sciences (Patient Square Capital’s platform). Ambros Therapeutics, Inc., a newly launched clinical-stage biotechnology company, has secured $125…
Enavate Sciences Co-Leads $125 Million Series A Financing for Ambros Therapeutics
